Document Detail

The Sympathetic Nervous System in Polycystic Ovary Syndrome: a novel therapeutic target?
MedLine Citation:
PMID:  22882204     Owner:  NLM     Status:  Publisher    
SUMMARY: Polycystic ovary syndrome (PCOS) is a common endocrine condition associated with long-term health risks including type 2 diabetes and vascular dysfunction in addition to reproductive sequelae. Many of the common features of PCOS, such as central obesity, hyperinsulinaemia and obstructive sleep apnoea (OSA) are associated with chronic sympathetic overactivity, suggesting that sympathoexcitation may be involved in the pathogenesis of this condition. Rodent models of polycystic ovaries have shown that ovarian sympathetic outflow may be increased, accompanied by elevated intra-ovarian synthesis of nerve growth factor (NGF) which may be involved in initiation of ovarian pathology. Patients with PCOS have evidence of increased muscle sympathetic nerve activity (MSNA), altered heart rate variability and attenuated heart rate recovery post-exercise, compared with age- and BMI-matched controls, suggesting a generalised increase in sympathetic nerve activity. Active weight loss can reduce MSNA and whole body noradrenaline spillover, whereas low frequency electroacupuncture decreased MSNA in overweight women with PCOS. Treatment of OSA with continuous positive airways pressure may reduce plasma noradrenaline levels and diastolic blood pressure, and improve cardiac sympathovagal balance. Renal sympathetic denervation also reduced MSNA, noradrenaline spillover and blood pressure in two PCOS subjects with hypertension, accompanied by improved insulin sensitivity. The sympathetic nervous system may thus offer a new therapeutic target in PCOS but larger and longer-term studies are needed before these treatments can be considered in clinical practice. © 2012 Blackwell Publishing Ltd.
Andrew Lansdown; D Aled Rees
Related Documents :
9375284 - New approaches to raynaud's phenomenon [corrected]
8238394 - Purine metabolic pathways in rat hindlimb perfusion model during ischemia and reperfusion.
7265464 - Carnitine distribution in subepicardial and subendocardial regions in normal and ischem...
12504814 - Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific ove...
16376234 - Compressive loads in longitudinal lateral meniscus tears: a biomechanical study in porc...
10690284 - Hemodynamic effects of nitric oxide synthase inhibition at steady state and following t...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-7
Journal Detail:
Title:  Clinical endocrinology     Volume:  -     ISSN:  1365-2265     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Centre for Endocrine and Diabetes Sciences, Institute of Experimental and Molecular Medicine, School of Medicine, Cardiff University, Cardiff, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcin...
Next Document:  The prevalence of chronic and episodic migraine in children and adolescents.